JONATHAN JAY MAZELSKY - 06 Aug 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Issuer symbol
IDXX
Transactions as of
06 Aug 2025
Net transactions value
-$16,506,351
Form type
4
Filing time
08 Aug 2025, 20:38:08 UTC
Previous filing
15 Jul 2025
Next filing
12 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MAZELSKY JONATHAN JAY President and CEO, Director ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky 08 Aug 2025 0001556270

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1,985,291 +29,260 +35% $67.85 112,571 06 Aug 2025 Direct F1
transaction IDXX Common Stock Sale $686,458 -1,095 -0.97% $626.90 111,476 06 Aug 2025 Direct F2
transaction IDXX Common Stock Sale $958,115 -1,525 -1.4% $628.27 109,951 06 Aug 2025 Direct F3
transaction IDXX Common Stock Sale $2,139,508 -3,397 -3.1% $629.82 106,554 06 Aug 2025 Direct F4
transaction IDXX Common Stock Sale $3,818,874 -6,056 -5.7% $630.59 100,498 06 Aug 2025 Direct F5
transaction IDXX Common Stock Sale $4,610,096 -7,299 -7.3% $631.61 93,199 06 Aug 2025 Direct F6
transaction IDXX Common Stock Sale $1,897,689 -3,000 -3.2% $632.56 90,199 06 Aug 2025 Direct F7
transaction IDXX Common Stock Sale $2,239,457 -3,526 -3.9% $635.13 86,673 06 Aug 2025 Direct F8
transaction IDXX Common Stock Sale $1,159,068 -1,822 -2.1% $636.15 84,851 06 Aug 2025 Direct F9
transaction IDXX Common Stock Sale $560,391 -880 -1% $636.81 83,971 06 Aug 2025 Direct F10
transaction IDXX Common Stock Sale $421,985 -660 -0.79% $639.37 83,311 06 Aug 2025 Direct F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -29,260 -100% 0 06 Aug 2025 Common Stock 29,260 $67.85 Direct F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
F2 Represents the weighted average price of the shares sold ranging from a low of $626.585 to a high of $627.44 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $627.72 to a high of $628.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $629.14 to a high of $630.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $630.14 to a high of $630.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Represents the weighted average price of the shares sold ranging from a low of $631.26 to a high of $632.15 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F7 Represents the weighted average price of the shares sold ranging from a low of $632.41 to a high of $633.30 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F8 Represents the weighted average price of the shares sold ranging from a low of $634.66 to a high of $635.64 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F9 Represents the weighted average price of the shares sold ranging from a low of $635.66 to a high of $636.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F10 Represents the weighted average price of the shares sold ranging from a low of $636.66 to a high of $637.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F11 Represents the weighted average price of the shares sold ranging from a low of $639.235 to a high of 639.49 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F12 Grant of option to buy 41,260 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2017.
F13 Not applicable